A Single- and Multiple-Dose Study of Enlicitide Chloride (MK-0616) in Healthy Chinese Adult Participants (MK 0616-010)

NCT06814106 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

37

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Enlicitide Chloride
DRUG: Placebo

Sponsor

Merck Sharp & Dohme LLC